Medtronic invests in diabetes management company MiniMed
This article was originally published in Clinica
Executive Summary
Medtronic is to invest $30 million in MiniMed, a manufacturer of advanced infusion systems for diabetes management, in return for gaining a 3.5% share of the company. The move comes a week after Medtronic agreed to buy spinal implant manufacturer Sofamor Danek in a share deal worth $3.6 billion (see Clinica No 833, p 1).